Showing 521 - 540 results of 870 for search '"Prostate"', query time: 0.06s Refine Results
  1. 521
  2. 522
  3. 523
  4. 524
  5. 525

    Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a meta-analysis by Ying Zhang, Xiao Zhou, Ran Xu, Guangcheng Luo, Xinjun Wang

    Published 2025-01-01
    “…Abstract Background In recent years, many studies have illustrated that the neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor of metastatic castration-resistant prostate cancer (mCRPC), but their conclusions are controversial. …”
    Get full text
    Article
  6. 526

    An App-Based Intervention With Behavioral Support to Promote Brisk Walking in People Diagnosed With Breast, Prostate, or Colorectal Cancer (APPROACH): Process Evaluation Study by Fiona Kennedy, Susan Smith, Rebecca J Beeken, Caroline Buck, Sarah Williams, Charlene Martin, Phillippa Lally, Abi Fisher

    Published 2025-02-01
    “…MethodsAdults (aged ≥18 y) with breast, prostate, or colorectal cancer who reported not meeting the UK guidelines for moderate-to-vigorous physical activity (≥150 min/wk) were recruited from a single hospital site in Yorkshire, United Kingdom. …”
    Get full text
    Article
  7. 527

    KORELASI LAMA OPERASI DENGAN PERUBAHAN KADAR NATRIUM PASCA OPERASI TRANSURETHRAL RESECTION OF THE PROSTATE DI RSUP DR. M. DJAMIL PADANG by Rani Novelty, Zelly Dia Rofinda, Etriyel Myh

    Published 2019-03-01
    “…Transurethral Resection of the Prostate (TURP) pada pasien Benign Prostatic Hyperplasia (BPH) dengan indikasi absolut operasi. menggunakan suatu cairan irigasi. …”
    Get full text
    Article
  8. 528
  9. 529

    Hubungan Antara Volume Prostat dan IPSS Score pada Pasien BPH di Rumah Sakit Siti Khodijah Muhammadiyah Cabang Sepanjang by Shakina Reza Waskita, Muslim Andala Putra, Nur Mujadiddah Mochtar, Budi Himawan

    Published 2024-09-01
    “…<p>Benign Prostatic Hyperplasia (BPH) is the growth of non-malignant cells or hyperplasia of prostate tissue, which causes Lower Urinary Tract Symptoms (LUTS) in men. …”
    Get full text
    Article
  10. 530
  11. 531
  12. 532

    Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting by Benjamin H. Lowentritt, Carmine Rossi, Erik Muser, Frederic Kinkead, Bronwyn Moore, Patrick Lefebvre, Dominic Pilon, Shawn Du

    Published 2024-08-01
    “…**Background:** The use of androgen receptor signaling inhibitors, including apalutamide, in combination with androgen deprivation therapy is recommended for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). …”
    Get full text
    Article
  13. 533
  14. 534
  15. 535
  16. 536

    The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study by Kiyohide Fujimoto, Yoshihiko Hirao, Yasuo Ohashi, Yasuhiro Shibata, Kohzo Fuji, Hidenori Tsuji, Katsuhito Miyazawa, Mikinobu Ohtani, Ryoji Furuya, Eitetsu Boku

    Published 2013-01-01
    “…The endpoints were changes in International Prostate Symptom Scores (IPSS), IPSS-QOL, International Index of Erectile Function-5, Qmax prostate volume, and residual urine volume. …”
    Get full text
    Article
  17. 537
  18. 538
  19. 539
  20. 540